200 related articles for article (PubMed ID: 32344303)
1. Oxytocin as a potential defence against Covid-19?
Soumier A; Sirigu A
Med Hypotheses; 2020 Jul; 140():109785. PubMed ID: 32344303
[No Abstract] [Full Text] [Related]
2. Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
Severa M; Farina C; Salvetti M; Coccia EM
Front Immunol; 2020; 11():1459. PubMed ID: 32655578
[No Abstract] [Full Text] [Related]
3. Purposing Saikosaponins for the treatment of COVID-19.
Bahbah EI; Negida A; Nabet MS
Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
[No Abstract] [Full Text] [Related]
4. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach.
Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B
Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439
[No Abstract] [Full Text] [Related]
5. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
Dal Moro F; Livi U
Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
[No Abstract] [Full Text] [Related]
6. Curing COVID-19.
The Lancet Infectious Diseases
Lancet Infect Dis; 2020 Oct; 20(10):1101. PubMed ID: 32919520
[No Abstract] [Full Text] [Related]
7. Treatments for COVID-19: where are we now?
Mendes A
Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
[No Abstract] [Full Text] [Related]
8. Current Perspective of Antiviral Strategies against COVID-19.
Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
[TBL] [Abstract][Full Text] [Related]
9. Plea for multitargeted interventions for severe COVID-19.
Gaborit BJ; Bergmann JF; Mussini C; Arribas JR; Behrens G; Walmsley S; Pozniak A; Raffi F
Lancet Infect Dis; 2020 Oct; 20(10):1122-1123. PubMed ID: 32325035
[No Abstract] [Full Text] [Related]
10. Investigating hypothiocyanite against SARS-CoV-2.
Cegolon L
Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009
[No Abstract] [Full Text] [Related]
11. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
Sargin G; Yavaşoğlu Sİ; Yavasoglu I
Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
[No Abstract] [Full Text] [Related]
12. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
13. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
14. Famotidine Against SARS-CoV2: A Hope or Hype?
Ghosh R; Chatterjee S; Dubey S; Lavie CJ
Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
[No Abstract] [Full Text] [Related]
15. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
Poulas K; Farsalinos K; Zanidis C
Front Immunol; 2020; 11():1373. PubMed ID: 32612613
[No Abstract] [Full Text] [Related]
16. Sofosbuvir as a potential option for the treatment of COVID-19.
Nourian A; Khalili H
Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Potential Therapeutic Options for COVID-19.
Austin D; Okour M
J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
[No Abstract] [Full Text] [Related]
18. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
19. Favipiravir, an antiviral for COVID-19?
Coomes EA; Haghbayan H
J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
[No Abstract] [Full Text] [Related]
20. Drug researchers pursue new lines of attack against COVID-19.
Harrison C
Nat Biotechnol; 2020 Jun; 38(6):659-662. PubMed ID: 32417850
[No Abstract] [Full Text] [Related]
[Next] [New Search]